Although the diagnosis of fibromyalgia has been controversial, the condition is now recognized as a legitimate clinical entity. But despite greater acceptance of the disorder by the medical community in recent years, fibromyalgia continues to be under-diagnosed or misdiagnosed.
Diagnosis of FS is difficult in part because symptoms are variable and tend to come and go and because standard laboratory tests and x-rays are not able to detect the syndrome. Lab tests may be ordered, however, to determine whether you have another condition with similar symptoms, such as rheumatoid arthritis, lupus, or hypothyroidism.
For an accurate diagnosis of fibromyalgia, look for a health care professional with experience identifying the syndrome. Many other illnesses share some of the same symptoms, including lupus, low thyroid, myositis and chronic fatigue syndrome. Rheumatologists or physiatrists are often experienced in diagnosing fibromyalgia. A rheumatologist is a doctor who specializes in disorders that affect the joints, muscles, tendons, ligaments and bones. A physiatrist is a physical medicine specialist who specializes in diagnosing and treating injuries and diseases causing pain, loss of function and disability.
In addition to the pain, sleeping difficulty and fatigue experienced by most fibromyalgia victims, FS patients also have extreme hypersensitivity, including:
* hypersensitivity to cold, especially in the hands and feet, often accompanied by color changes; this condition is known as Raynaud's phenomenon
* hypersensitivity to distension of the bladder with even a tiny amount of urine, leading to irritable bladder
* hypersensitivity to the menstrual cycle, when hormonal changes in pain perception occur
* hypersensitivity to sound, touch, light and odor
* hypersensitivity to vulvular stimulation, called vulvar vestibulitis or vulvodynia, characterized by a painful vulvar region and painful sexual intercourse
Other symptoms include:
* stiffness, particularly in the early morning, after prolonged sitting or standing, or with changes in temperature or relative humidity
* increased headaches or facial pain, including frequent migraine, tension or vascular headaches, or pain behind the eyes
* light-headedness and/or balance problems
* abdominal discomfort, often referred to as irritable bowel syndrome, which can include abdominal pain, bloating, constipation and/or diarrhea (some of this discomfort may be due to bacterial overgrowth)
* paresthesia (numbness or tingling), often in the hands or feet. Sometimes called "neuropathy," a condition described as a prickling or burning sensation, although in FS, unlike diabetes, there is no evidence of nerve damage.
* skin problems, including blotchy or itchy skin; also, a sensation of swelling, particularly in the extremities--such as a ring suddenly not fitting--is a common symptom
Other symptoms include cognitive disorders, most often short-term memory lapses and difficulty concentrating, as well as anxiety and depression related to the chronic pain and fatigue of fibromyalgia.
Of course, many of these symptoms can apply to a variety of diseases. To resolve the ambiguities, the American College of Rheumatology (ACR) in 1990 developed two specific criteria for diagnosing FS:
* chronic, widespread, musculoskeletal pain of longer than three months duration in all four quadrants of the body
* multiple tender points throughout the body--18 have been identified by the ACR and a patient must have 11 of the 18 for a diagnosis of fibromyalgia to be considered. A tender point is found by palpation--applying approximately nine pounds of pressure to the area with the fingers; an area that hurts when the health care professional palpates it is a tender point. An illustration that shows the various tender point sites on the human body can be viewed on the National Fibromyalgia Partnership, Inc. Web site, located at http://www.fmpartnership.org/FMPartnership.htm.
"COX-2 Selective and Non-Selective Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)." U.S. Food and Drug Administration Center for Drug Evaluation and Research. http://www.fda.gov. Updated April 15, 2005. Accessed June 3, 2005.
"FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily Withdraws Its Product." U.S. Food and Drug Administration. http://www.fda.gov. Accessed October 1, 2004.
"About Fibromyalgia: What Causes Fibromyalgia?" National Fibromyalgia Association. http://www.fmaware.org. Accessed June 11, 2004.
"About Fibromyalgia: How is Fibromyalgia Treated?" National Fibromyalgia Association. http://www.fmaware.org. Accessed June 11, 2004.
Clinical Trials in Fibromyalgia. ClinicalTrials.gov. National Library of Medicine. http://www.clinicaltrials.gov. Accessed June 11, 2004.
Fibromyalgia." The National Women's Health Information Center. http://www.4woman.gov. Accessed June 11, 2004.
"Questions and Answers About Fibromyalgia." National Institute of Arthritis and Musculoskeletal and Skin Diseases. Published Dec. 1999. http://www.niams.nih.gov. Accessed June 11, 2004.
Cote, K. Harvey M. "Sleep, Daytime Symptoms and Cognitive Performance in Patients with Fibromyalgia. Journal of Rheumatology. 1997: 24:2014-23.
Moldofsky, H. "Fibromyalgia: An Enigmatic Illness and Its Management." The Canadian Journal of Diagnosis. Oct. 1999. 73-80.
Pimentel, M. Hallegua, D. Lin, HC. et al. "Improvement in Fibromyalgia with Treatment of Small Intestinal Bacterial Overgrowth (SIBO): A Double Blind Randomized Study." Arthritis and Rheumatism. 42:S343, 1999. Accessed June 11, 2004.
Small Intestinal Bacterial Overgrowth in Fibromyalgia. FibroFree Fibromyalgia Recovery Program. http://www.fibrofree.com. Accessed June 11, 2004.
Yunus, M. "Fibromyalgia and overlapping syndromes." Fibromyalgia Network. http://www.fmnetnews.com. Accessed June 11, 2004.
Chang, L. "The Association of Functional Gastrointestinal Disorders and Fibromyalgia." European Journal of Surgery; 1998; Supplement 583: 32-36.
Fibromyalgia and Chronic Myofascial Pain. Excerpted from "Fibromyalgia and Chronic Myofascial Pain Syndrome: A Survival Guide" by D.J. Starlanyl and M.E. Copeland. Revbised April 7, 2004. http://www.sover.net. Accessed June 11, 2004.
Burckhardt, C. "How Pain Affects the Mind." Presentation at FAME 2000 International Fibromyalgia Conference, 5/20/99 - 5/21/00. Universal City, Calif.
Jasmin, L. "FMS: A CNS Disease." Fibromyalgia Network (Newsletter). April 21, 2000.
Engstrom, D. "Biofeedback" Presentation at FAME 2000 International Fibromyalgia Conference, 5/20/99 - 5/21/00. Universal City, Calif.
Engstom, D. "Coping with Emotions: The Role of the Psychologist/Psychiatrist." Presentation at FAME 2000 International Fibromyalgia Conference, 5/20/99 - 5/21/00. Universal City, Calif.
Moldofsky, H. "Sleep, neuroimmune and neuroendocrine functions in fibromyalgia and chronic fatigue syndrome." Advances in Neruoimmunology. Vol. 5. 1995. 39-56.Pillemer, S. Bradley, L. Crofford, L. et al. "The Neuroscience and Endocrinology of Fibromyalgia." Arthritis & Rheumatism. Nov. 1997. Vol. 40, No. 11. 1928-1939.
Bennett, R. "Chronic Widespread Pain and the Fibromyalgia Construct." Pain Digest. 1999. 9:292-298.
Russell, J. "Fibromyalgia Syndrome." Presentation at FAME 2000 International Fibromyalgia Conference, 5/20/99 - 5/21/00. Universal City, Calif.
Wallace, D, Mariana Linker-Israeli, David Hallegua, et al. "Cytokines play an etiopathogenetic role in fibromyalgia: A pilot study." Abstract 950156. Presented at the American College of Rheumatology, 64th Annual Scientific Meeting, 4/30/00.
Hardy, M. "Fibromyalgia and Integrative Medicine: Evaluation of Efficacy & Safety." Presentation at FAME 2000 International Fibromyalgia Conference, 5/20/99 - 5/21/00. Universal City, Calif.
"What Research Is Being Conducted on Fibromyalgia?" National Institute of Arthritis and Musculoskeletal and Skin Diseases. Published Dec. 1999. http://www.niams.nih.gov. Accessed June 11, 2004.
"Fibromyalgia." Mayo Foundation for Medical Education and Research. April 24, 2003. http://www.mayoclinic.com. Accessed June 11, 2004.
"Fibromyalgia Fact Sheet" American College of Rheumatology. 2000. Updated October 2003.http://www.rheumatology.org. Accessed June 11, 2004.
"FM Monograph" National Fibromyalgia Partnership, Inc. Copyright 2004. http://www.fmpartnership.org. Accessed June 11, 2004.
"Fibromyalgia Medicationst" The Arthritis Foundation. 2004.http://www.arthritis.org. Accessed June 11, 2004.
Editorial Staff of the National Women's Health Resource Center 2002/07/31 2005/06/08 Fibromyalgia syndrome (FS) is a chronic disorder characterized by widespread musculoskeletal pain, fatigue, multiple tender points and poor sleep. "Tender points" refers to tenderness that occurs in precise, localized areas, particularly in the neck, spine, shoulders and hips. Chronic pain,Corticosteroids,Fibromyalgia,Nonsteroidal anti-inflammatory drugs,NSAIDs,Parenthesia,Raynaud's phenomenon,Tender points
|Printer friendly Cite/link Email Feedback|
|Publication:||NWHRC Health Center - Fibromyalgia|
|Date:||Jun 8, 2005|
|Previous Article:||Fibromyalgia; Overview.|
|Next Article:||Fibromyalgia; Treatment.|